Clinical trial for Hearing Loss
Official title Innovations in Hearing Accessibility and Technology (IHAT) Study
ClinicalTrials.gov ID: NCT06689865
What this study is testing
- What it's testing
- The study compares how OTC hearing aids and prescription‑fitted aids affect hearing experiences, thinking skills, brain activity, and costs. It also looks at which people prefer each option.
- Who it's for
- Adults who have mild to moderate hearing loss.
- What's involved
- Participants will use either an OTC hearing aid or a prescription‑fitted hearing aid and will complete questionnaires, possibly some cognitive tests, and other assessments during study visits.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Adult onset, bilateral, mild-to-moderate sensorineural hearing loss documented by audiological evaluation
- Aged 40 years or older
- No previous HA experience greater than 3 months
- Able to read and understand patient education materials
- Willing to be assigned by chance to one of the four groups, and
You likely can't join if
- Hearing loss that is too severe for OTC HAs
- Middle ear disorders or conductive pathology present
- Asymmetrical hearing loss
- Diagnosed neurological condition such as dementia or Parkinson's disease or a score lower than 25 on the MOCA
- Non-English speaking as it may impact the ability to complete our test battery
See the full eligibility criteria
- Adult onset, bilateral, mild-to-moderate sensorineural hearing loss documented by audiological evaluation
- Aged 40 years or older
- No previous HA experience greater than 3 months
- Able to read and understand patient education materials
- Willing to be assigned by chance to one of the four groups, and
- Owns a smartphone
- Hearing loss that is too severe for OTC HAs
- Middle ear disorders or conductive pathology present
- Asymmetrical hearing loss
- Diagnosed neurological condition such as dementia or Parkinson's disease or a score lower than 25 on the MOCA
- Non-English speaking as it may impact the ability to complete our test battery
The study team makes the final eligibility decision.
Where it is enrolling
- Aurora, Colorado, United States
- Boulder, Colorado, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Aurora, Colorado, United States; Boulder, Colorado, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.